|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2000-9-14
|
|
pubmed:abstractText |
Impaired regulation of apoptosis is known to be associated with the development of various cancers. Fas receptor (APO-1/CD95) binding to its ligand, Fas-ligand (Fas-L), has been shown to trigger apoptosis in various cell types.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0007-0963
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
143
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
307-12
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10951137-Antigens, CD95,
pubmed-meshheading:10951137-Antigens, Neoplasm,
pubmed-meshheading:10951137-Apoptosis,
pubmed-meshheading:10951137-Disease Progression,
pubmed-meshheading:10951137-Fas Ligand Protein,
pubmed-meshheading:10951137-Flow Cytometry,
pubmed-meshheading:10951137-Humans,
pubmed-meshheading:10951137-Ligands,
pubmed-meshheading:10951137-Melanoma,
pubmed-meshheading:10951137-Membrane Glycoproteins,
pubmed-meshheading:10951137-Neoplasm Proteins,
pubmed-meshheading:10951137-Skin Neoplasms
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
A comparative study of Fas and Fas-ligand expression during melanoma progression.
|
|
pubmed:affiliation |
Medical Oncology Department, Salpêtrière Hospital, 47 boulevard de l'Hôpital, 75013 Paris, France. claude.soubrane@psl.ap-hop-paris.fr
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
